Runnymede Capital Advisors’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,990	Closed	-$145K	–	262
2025 Q1	$145K	Sell	5,990 -300	-5%	-$7.25K	0.14%	82
2024 Q4	$253K	Buy	+6,290	New	+$253K	0.22%	64